Asunto(s)
Biotecnología , Atención a la Salud , Medicina , Calidad de la Atención de Salud , Biotecnología/legislación & jurisprudencia , Biotecnología/tendencias , Gestión Clínica/legislación & jurisprudencia , Atención a la Salud/legislación & jurisprudencia , Atención a la Salud/normas , Humanos , Legislación Médica/tendencias , Medicina/normas , Medicina/tendencias , Calidad de la Atención de Salud/legislación & jurisprudencia , Calidad de la Atención de Salud/normas , Responsabilidad SocialRESUMEN
The Access to COVID-19 Tools Accelerator (ACT-A) is a multistakeholder initiative quickly constructed in the early months of the COVID-19 pandemic to respond to a catastrophic breakdown in global cooperation. ACT-A is now the largest international effort to achieve equitable access to COVID-19 health technologies, and its governance is a matter of broad public importance. We traced the evolution of ACT-A's governance through publicly available documents and analysed it against three principles embedded in the founding mission statement of ACT-A: participation, transparency, and accountability. We found three challenges to realising these principles. First, the roles of the various organisations in ACT-A decision making are unclear, obscuring who might be accountable to whom and for what. Second, the absence of a clearly defined decision making body; ACT-A instead has multiple centres of legally binding decision making and uneven arrangements for information transparency, inhibiting meaningful participation. Third, the nearly indiscernible role of governments in ACT-A, raising key questions about political legitimacy and channels for public accountability. With global public health and billions in public funding at stake, short-term improvements to governance arrangements can and should now be made. Efforts to strengthen pandemic preparedness for the future require attention to ethical, legitimate arrangements for governance.
Asunto(s)
COVID-19/terapia , Gestión Clínica/organización & administración , Salud Global , Cooperación Internacional , Pandemias/prevención & control , COVID-19/diagnóstico , COVID-19/epidemiología , Toma de Decisiones en la Organización , Humanos , Administración en Salud PúblicaAsunto(s)
Vacunas contra la COVID-19/provisión & distribución , COVID-19/prevención & control , Planificación en Desastres/economía , Pandemias/prevención & control , Investigación Biomédica , COVID-19/diagnóstico , COVID-19/epidemiología , COVID-19/virología , Gestión Clínica/organización & administración , Diplomacia/métodos , Salud Global/normas , Inequidades en Salud , Implementación de Plan de Salud/organización & administración , Directrices para la Planificación en Salud , Accesibilidad a los Servicios de Salud/tendencias , Humanos , SARS-CoV-2/genética , Poblaciones Vulnerables/estadística & datos numéricosRESUMEN
La pandemia SARS-CoV-2 ha desafiado el despliegue de todo el equipo de salud, movilizando no solo un recurso humano, también equipamiento, insumos y una infraestructura, que permita responder una alta demanda de pacientes críticos, que requirió abrir más camas críticas, manejada por un personal sanitario sin experiencia en UCI y con equipamiento e insumos limitados. El trabajo en equipo, la comunicación efectiva y el liderazgo en enfermería, son competencias esenciales en la primera ola de la pandemia, por lo que el objetivo de este artículo es describir la innovación de la orgánica estructural de enfermería, especialmente en las áreas de hospitalización de paciente crítico, para velar por el cuidado del paciente, la familia y el equipo de salud.
The SARS-CoV-2 pandemic has challenged the deployment of the entire health team, mobilizing not only a human resource, but also equipment, supplies and an infrastructure, which allows responding to a high demand for critical patients, which required opening more critical beds, managed by health personnel without ICU experience and with limited equipment and supplies. Teamwork, effective communication and leadership in nursing are essential competencies in the first wave of the pandemic, so the objective of this article is to describe the innovation of the structural nursing organization, especially in hospitalization areas. Critical patient, to ensure the care of the patient, the family and the health team
Asunto(s)
Humanos , Hospitales Privados/organización & administración , COVID-19 , Unidades de Cuidados Intensivos/organización & administración , Atención de Enfermería/organización & administración , Chile , Atención Dirigida al Paciente , Educación en Enfermería , Gestión Clínica , Pandemias , Relaciones Interprofesionales , Relaciones Enfermero-PacienteRESUMEN
INTRODUCTION: The authors presented a retrospective study in the surgical activity of the HUB center for Hand Surgery and Microsurgery in Emilia-Romagna comparing the data between March and April 2020, in the peak of Covid pandemic, with the same period in 2019. MATERIALS AND METHODS: During the two months period of March-April 2020 versus 2019 the authors analyzed the surgical procedures performed in elective and emergency surgery with hospitalization and Day or Outpatient surgery regime. Surgical treatments with no hospitalization were planned in the Day-Surgery Service. The financing system impacts were analyzed according to the Diagnosis Related Groups (DRG), the costs accounting method mostly used in European countries. RESULTS: An overall reduction of 68.5% was recorded in surgical procedures, with a more relevant reduction of 92.3% in elective surgery and a significantly less relevant reduction of 37.2% in urgent one. Replantation did not present a reduction in number of cases, while cutting lesions of tendons at the hand and fingers increased such as the bone and ligament injuries during domestic accidents. The negative impact in the financial system recorded a reduction of 32.5%. DISCUSSION: The epidemiology of hand trauma looks not only at the artisanal and industrial injuries, but also mostly at the accidents in daily life activities. The data of the study evidenced the significantly increase in the injuries occurring in the domestic environment. Elective surgery was canceled. The 86% of surgical procedures performed were urgent ones and the 72.8% of these were possible in Day and Outpatient surgery with significantly reduction in hospitalization. All procedures followed a rigid process for patient and healthcare workers with regard for personal protection and safety. Telemedicine was arranged in emergencies, and economic damage was analyzed also in the following rebound effect during summer period. CONCLUSIONS: The significantly less reduction recorded in urgent surgery vs the more relevant reduction in elective one showed how the hand injuries remained a major issue also during the lockdown. The data highlighted the relevant role of the organizational aspects of the surgical procedures and planning in hand trauma. Despite the financial impact of the elective surgery, the presence of a functional and skill Emergency Service and Day-Surgery Service resulted fundamental in the efficacy and efficiency of the patient management and in containment of economic damage. The telemedicine was significantly limited by liability and risk management issues.
Asunto(s)
COVID-19 , Traumatismos de la Mano , COVID-19/epidemiología , Gestión Clínica , Control de Enfermedades Transmisibles , Mano/cirugía , Traumatismos de la Mano/epidemiología , Traumatismos de la Mano/cirugía , Humanos , Microcirugia , Pandemias/prevención & control , Estudios RetrospectivosRESUMEN
Multiple national and international trends and drivers are radically changing what biological security means for the United Kingdom (UK). New technologies present novel opportunities and challenges, and globalisation has created new pathways and increased the speed, volume and routes by which organisms can spread. The UK Biological Security Strategy (2018) acknowledges the importance of research on biological security in the UK. Given the breadth of potential research, a targeted agenda identifying the questions most critical to effective and coordinated progress in different disciplines of biological security is required. We used expert elicitation to generate 80 policy-relevant research questions considered by participants to have the greatest impact on UK biological security. Drawing on a collaboratively-developed set of 450 questions, proposed by 41 experts from academia, industry and the UK government (consulting 168 additional experts) we subdivided the final 80 questions into six categories: bioengineering; communication and behaviour; disease threats (including pandemics); governance and policy; invasive alien species; and securing biological materials and securing against misuse. Initially, the questions were ranked through a voting process and then reduced and refined to 80 during a one-day workshop with 35 participants from a variety of disciplines. Consistently emerging themes included: the nature of current and potential biological security threats, the efficacy of existing management actions, and the most appropriate future options. The resulting questions offer a research agenda for biological security in the UK that can assist the targeting of research resources and inform the implementation of the UK Biological Security Strategy. These questions include research that could aid with the mitigation of Covid-19, and preparation for the next pandemic. We hope that our structured and rigorous approach to creating a biological security research agenda will be replicated in other countries and regions. The world, not just the UK, is in need of a thoughtful approach to directing biological security research to tackle the emerging issues.
Asunto(s)
Pandemias/prevención & control , Medidas de Seguridad/tendencias , Bioterrorismo/prevención & control , COVID-19/prevención & control , Gestión Clínica/tendencias , Comunicación , Transmisión de Enfermedad Infecciosa/prevención & control , Transmisión de Enfermedad Infecciosa/estadística & datos numéricos , Humanos , Pandemias/estadística & datos numéricos , Políticas , SARS-CoV-2/patogenicidad , Medidas de Seguridad/estadística & datos numéricos , Encuestas y Cuestionarios , Reino Unido/epidemiologíaRESUMEN
China reported cases of a severe form of pneumonia in December 2019 from Wuhan city, Hubei province. The virus causing this illness was identified as the novel Coronavirus 2019, which has now been christened Covid-19. The illness is characterised by fever, cough, body pain and in a few cases, progression to acute respiratory distress syndrome (ARDS) which marks very serious damage to the lungs (1-4). Apart from Wuhan, China, the virus has spread to 26 other countries as on February 18, 2020. Of these 26 countries, the cases of Covid-19 have been exported directly from China in 23 of them. As on February 23, 2020, a total of 78,811 confirmed cases, 2445 deaths have been reported globally. The World Health Organization declared this as a Public Health Emergency of International Concern (PHEIC) on January 30, 2020 (5).
Asunto(s)
Gestión Clínica , Infecciones por Coronavirus , Atención a la Salud , Recursos en Salud , Pandemias , Neumonía Viral , Betacoronavirus , COVID-19 , Defensa Civil , Humanos , India/epidemiología , SARS-CoV-2RESUMEN
On January 23, 2020, the Chinese government announced the city lockdown of Wuhan. Since then, there have been controversial debates among experts about the efficacy of mass quarantine, the oldest and probably one of the most effective methods for controlling infectious disease outbreaks. The impact of health policymaking section of health system governance becomes visible to all stakeholders and the public in such emergency contexts. The success and failure of such policies should be evaluated in order to find the proper course of action for the local and international communities. In this review, we aim to investigate the efficacy of mass quarantine in China during the coronavirus disease 2019 (COVID-19) pandemic. We found good quality evidence for the effectiveness of mass quarantine during the current stage of COVID-19 pandemic, and these strategies seem to have been highly effective in controlling the spread of the disease.